Comparison of Gangjihwan and Combination of Gangjihwan and Gamisochehwan in the Improvement Effects of Nonalcoholic Fatty Liver Disease in a High Fat Diet-Fed NAFLD Mouse Model |
Jang, Du Hyon
(Chungnam Korean Medicine Clinic)
Jung, Yang Sam (Jungyangsam Korean Medicine Clinic) Kim, Jong Hoon (Neungin Korean Medicine Clinic) Kim, Byeong Chul (Goryo Korean Medicine Clinic) Seok, Hoa Jun (Soojung Korean Medicine Clinic) Yoo, Jae Sang (Bonghwang Korean Medicine Clinic) Ku, Ja Ryong (Soricheong Luck Korean Medicine Clinic) Yoon, Ki Hyeon (Dept. of Formula Sciences and Research Institute of Korean Medicine for Diabetes and Obesity, College of Korean Medicine, Dong-Eui University) Jo, Ju Heum (Woosim Korean Medicine Clinic) Lee, Hye Rim (Dept. of Formula Sciences and Research Institute of Korean Medicine for Diabetes and Obesity, College of Korean Medicine, Dong-Eui University) Roh, Jong Seong (Dept. of Formula Sciences and Research Institute of Korean Medicine for Diabetes and Obesity, College of Korean Medicine, Dong-Eui University) Yun, Ho Young (Dept. of Formula Sciences and Research Institute of Korean Medicine for Diabetes and Obesity, College of Korean Medicine, Dong-Eui University) Yoon, Michung (Dept. of Life Sciences, Mok-Won University) Shin, Soon Shik (Dept. of Formula Sciences and Research Institute of Korean Medicine for Diabetes and Obesity, College of Korean Medicine, Dong-Eui University) |
1 | Kim TK, Jung WS, Park SW, Cho KH, Kim YS. Comparison of efficacy and safety between Chunghyul-dan(HH-333) and Atorvastatin(Lipitor). Kor J of Orient Int Med. 2003; 24(4): 837-845. |
2 | Prineas RJ, Folsom AR, Kaye SA. Central adiposity and increased risk of coronary artery disease mortality in older women. Ann Epidermiol. 1993; 3: 35-41. DOI ScienceOn |
3 | Park HS, Kim MW, Shin ES. Effect of weight control on hepatic abnormalities in obese patients with fatty liver. J Korean Med Sci, 1995; 10: 414-421. 과학기술학회마을 DOI |
4 | Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut. 2004; 53: 413-419. DOI ScienceOn |
5 | Park KS, Jang BK, Kwon KM, Chung WJ, Cho KB, Hwang JS, Ahn SH, Mun KC, Kim YH. Antioxidant status in nonalcoholic steatohepatitis. Korea J Hepatol. 2005; 11(2): 135-143. 과학기술학회마을 |
6 | Day CP, James OF. Steatohepatitis: a tale of two "hits"?. Gastroenterol. 1998; 114: 842-845. DOI ScienceOn |
7 | Durazzo M, Belci P, Collo A, Grisoglio E, Bo S. Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease. Int J Hepatol. 2012; 2012: 464706. |
8 | Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999; 19: 221-229. DOI ScienceOn |
9 | Powell EE, Cooksley WG, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80. DOI |
10 | Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994; 107: 1103-1109. DOI |
11 | Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J of Hepatol. 2005; 42(1): 132-138. |
12 | Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 2001; 50: 1844-1850. DOI ScienceOn |
13 | MGaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013; 5: 1544-1560. DOI |
14 | National Institute of Food and Drug Safety Evaluation. Influence of dietary intake on non-alcoholic fatty liver disease in Korean. 2012: 1. |
15 | Reynoso E, Lavine JE. NAFLD: The role of exercise in treating NAFLD. Nat Rev Gastroenterol and Hepatol. 2012; 9: 368-370. DOI |
16 | Ye Ji Ahn, Ki Hyeon Yoon, Ju Heum Jo, Du Hyon Jang, Yang Sam Jung, Jong Hoon Kim, Byeong Chul Kim, Hoa Jun Seok, Jae Sang Yoo, Ja Ryong Ku, Michung Yoon, Soon Shik Shin. Gangjihwan Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed C57BL/6N Mice. Kor. J. Herbology 2014; 29(2): 47-54. 과학기술학회마을 DOI ScienceOn |
17 | Yun Gil Yeong. Clinical Formula Science of Korean Medicine. Seoul: Myeongbo Press, 1985: 387. |